Printer Friendly

INTERPHARM LABORATORIES REPORTS 1991 THIRD QUARTER AND NINE MONTHS SALES AND EARNINGS

          INTERPHARM LABORATORIES REPORTS 1991 THIRD QUARTER
                  AND NINE MONTHS SALES AND EARNINGS
    NESS-ZIONA, Israel, Nov. 14 /PRNewswire/ -- InterPharm Laboratories Limited (NASDAQ: IPLLF) today reported net sales of US $9.1 million for the third quarter ending Sept. 30, 1991, compared with $7.0 million for the same period last year, an increase of 31 percent.  Net income increased by 8 percent to $1.6 million or 25 cents per share, compared with $1.4 million or 23 cents per share in 1990.
    Commenting on these results, Dr. Yoram Karmon, president and chief executive officer of the company, remarked:  "This performance was achieved primarily as a result of the increase in sales of FRONE(R), our native beta interferon, and increased production efficiency."
    Net sales for nine months ending Sept. 30, 1991 rose 53 percent to $25.2 million, compared with $16.4 million during the same period in 1990.
    Net income rose 149 percent to $3.4 million or 54 cents per share, compared with $1.4 million or 22 cents per share for the first nine months of 1990.
    "We will continue vigorously to pursue our R&D goals," said Dr. Karmon, "This quarter our gross R&D expenditures rose by 50 percent to $1.7 million compared with $1.1 million for the same period last year."
    InterPharm Laboratories Limited is a research-based developer, manufacturer and marketer of biological pharmaceuticals.
    InterPharm Laboratories Ltd. is a member of The Ares-Serono Group, a worldwide developer and marketer of pharmaceutical and diagnostic products with executive headquarters in Geneva, Switzerland, and operational headquarters in Boston, Mass., U.S.A.  The Group operates subsidiaries and manufacturing facilities in more than 20 countries.
    Below is a summary of unaudited comparative results.  (All amounts are in US dollars).
                      INTERPHARM LABORATORIES LTD.
                           FINANCIAL RESULTS
                          Three Months Ended        Nine Months Ended
                          9/30/91     9/30/90      9/30/91      9/30/90
    Net sales          $9,145,962  $6,970,304  $25,164,739  $16,414,529
    Operating profit    1,685,054   1,421,804    3,478,872    1,599,487
    Financial expense-
     net                 (125,766)   (114,378)    (106,230)    (277,930)
    Net income          1,559,288   1,448,426    3,372,642    1,352,557
    Earnings per share   25 cents    23 cents     54 cents     22 cents
    Weighted average
     number of shares
     outstanding        6,242,385   6,237,385    6,240,022    6,237,385
    -0-                               11/14/91
    /CONTACT: Gina Cella of Ares-Serono Group, 617-982-9000, ext. 251/
    (IPLLF) CO:  InterPharm Laboratories, Ltd.; The Ares-Serono Group ST:  Massachusetts IN:  MTC SU:  ERN KM-DD -- NE002 -- 4298 11/14/91 09:39 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 14, 1991
Words:434
Previous Article:PITTSBURGH COMPANIES PLAY MAJOR ROLE IN DEVELOPMENT OF NATURAL GAS VEHICLES
Next Article:NYMAGIC REPORTS THIRD-QUARTER EARNINGS, SEPT. 30, 1991
Topics:


Related Articles
FOREST LABORATORIES REPORTS RECORD FISCAL THIRD QUARTER RESULTS
INTERPHARM LABORATORIES REPORTS AN INCREASE IN SALES AND NET INCOME IN 1991
PHARMAKINETICS LABORATORIES, INC., ANNOUNCES THIRD QUARTER EARNINGS
BARR LABORATORIES RELEASES THIRD QUARTER FINANCIAL RESULTS
INTERPHARM LABORATORIES LTD. REPORTS EARNINGS AND INCOME FOR THE SECOND QUARTER OF 1992
ABBOTT ACHIEVES RECORD SALES, EARNINGS IN THIRD QUARTER; EARNINGS PER SHARE INCREASE 13.8 PERCENT
INTERPHARM LABORATORIES LTD. REPORTS THIRD QUARTER AND NINE MONTHS EARNINGS AND INCOME
INTERPHARM LABORATORIES LTD. REPORTS 1993 FIRST QUARTER RESULTS
INTERPHARM LABORATORIES LIMITED REPORTS 1994 FIRST QUARTER RESULTS
INTERPHARM LABORATORIES LTD. REPORTS 1994 THIRD QUARTER RESULTS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters